(September 8, 2016) Continuing growth for Stevanato Group, which specializes in products, processes and solutions for the pharmaceutical industry (packaging for glass tubing, plastic injection molded systems, machinery for the transformation of the glass tube and inspection systems , equipment for assembly and solutions for serialization). In the first half of this year, the Group recorded a revenue increase of around 40% thanks to the start of operations of integration of the new companies that have become part of the Group perimeter and that led to further expand the activities with new production plants in Germany, Romania and the United States. “The period was particularly intense because we have begun to lay the foundations for the development of our strategy, which plans for the future to expand the product portfolio, joining the current offering integrated systems for drug delivery, moving in the high end of the value chain”, explains Franco Stevanato, CEO of the group. In early February, Stevanato Group has begun construction works of the new production site in Sete Lagoas in Brazil (for which it planned to invest about 30 million euro), which will be operational in early 2017.